A multi-million ounce gold project acquisition sparked much speculation in shares of a gold junior Tuesday. Here’s some small stocks making big moves on Tuesday, June 9, 2020 (as of 4 pm EST):
Artemis Gold Inc. (TSXV:ARTG) shares surged 29% to $2.34 on Tuesday after the gold junior agreed to acquire the Blackwater Gold Project in British Columbia from New Gold Inc, in consideration for $190 million in cash. The Blackwater Project has a current Proven & Probable open-pittable reserve of 8.2 million gold ounces grading 0.74 g/t.
As well, shares of Titan Medical Inc. (TSX:TMD) climbed as much as 18% before ending off 1% at $1.68 as the medical device company said it has entered into a settlement agreement with Naglreiter Consulting, LLC, to settle claims in the lawsuit pending in the United States District Court for the Southern District of Florida.
IntelGenx Corp. (TSXV:IGX) stock, meanwhile, continued to move higher Tuesday, up 16% to $0.44 following a 27% gain on Monday, after the drug delivery company reported that it has received a cannabis micro-processing license from Health Canada for the Company’s Montreal facility.
Finally, Datametrex AI Limited (TSXV:DM) shares rose as much as 18% after the Company announced that Seasun Biomaterial’s 20-minute rapid Nucleic Acid test kit, AQ-TOP COVID-19 Rapid Detection Kit, which is distributed by Datametrex, has received authorization from the U.S. Food & Drug Administration Emergency Use Authorizations for Medical Devices.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.